The FDA decided in a 10:7 vote to approve Provention Bio’s teplizumab, a drug that could delay the onset of type 1 #diabetes for up to two years for high-risk individuals. Would you want to delay your #t1d diagnosis? Tell us more in the comments!
We asked dQ&A Community Members to share their experiences with #stigma in #diabetes. Results showed a lack of support from HCPs that impacts care. Broader social stigma poses additional challenges in day-to-day diabetes management. Read more: https://t.co/RXbVY1souo
We want to chat with people with #t2#diabetes that use #Toujeo Max or #Tresiba U200 #insulin. If you qualify and participate in our study, we will thank you with a $125 gift!
Please share with family members or friends🤪
https://t.co/mSuqDpVL36
Over 5,000 #PWD disclosed their primary pharmacy and rated their willingness to recommend that store.
dQ&A used a ranking system to grade top pharmacies into statistically distinct groups; overall winners were @SamsClub@Publix@Costco and @USMedSup
https://t.co/fH97j2WVXw
As unemployment rates surge, many living w/ #diabetes struggle to afford #insulin & other needed supplies amid #COVID19. This alarming data released in partnership with @dQAresearch underscores why we’re pushing for #HealthEquityNow: https://t.co/XlVxFWcIDK
Nice work from the dQ&A team - Understanding the CGM Tidal Wave Part 2 – Barriers to CGM Adoption and the Ambulatory Glucose Profile https://t.co/znFC8AEOLg
Join @diaTribeNews in a conversation with experts in health equity to explore the systemic changes needed to bring the best care possible to all people with diabetes!
This is an amazing FREE event that you can register for by clicking here: https://t.co/vV47XDQzbm
@dQAresearch surveyed 2,540 CGM users with type 1 or type 2 diabetes to find out how aware they are of their own time in range: 87% of respondents knew how much time they spend in range daily. https://t.co/c7PgUpKVYt
Check out this fantastic video of our Associates at diaTribe, @dQAresearch, and Close Concerns. We are lucky to have them on our team: https://t.co/MS8tAaZvM0 #DiabetesForum2020
Our focus is on diabetes and healthcare – but systemic inequality is itself a public health issue. Our hearts are heavy at the pain felt by the Black community. We are committed to a more equitable future in society and diabetes; we invite you to join us https://t.co/lIrsbRG2C2
If you are uninsured or have recently lost your employer-based insurance, it might seem like your options for managing your diabetes are limited. We’ve organized details on various assistance programs and resources to help you navigate this. https://t.co/saYJ5k74pz #diabetes
An extraordinary response from our Canada community on how #covid19 is affecting their #diabetes care. Beyond diabetes supplies, this report also explores the percentage of respondents who report poor #wellbeing according to the Who-5. https://t.co/X1aZMkWhHY
In Europe, the Dexcom G6 continuous glucose monitor received approval for pregnant women with diabetes. Find out the details here. @diaTribeNews https://t.co/EE6ezuBCJU
Novo Nordisk has joined the companies providing access to insulin for people with #diabetes amidst the #coronavirus pandemic.
Learn more in the article from @diaTribeNews https://t.co/wp6IPCOfnR
In our recent survey asking Community Members about the effects of #coronavirus on their diabetes care, we received over 2,400 incredibly insightful verbatim responses. See our full report here https://t.co/42Z2cJchJc